The top global medtech industry dynamics identified by the G-MedTech Research team over the past week, briefly presented in multiple languages.

Bosch and Randox Laboratories plan to invest approximately €150 million in the joint research, development and commercialization of new tests for Bosch Healthcare’s Vivalytic analysis platform to develop a sepsis IVD grade test that will be the first to use the highly innovative BioMEMS technology. Bosch has defined medical technology as a strategic growth field and aims to achieve a leading position in this market with its Vivalytic analysis platform.

OMRON Healthcare acquires Luscii Healthtech, a Dutch-based digital native pioneer in intelligent remote care and virtual wards, which provides a fully customizable platform and app for home care for over 150 diseases, including those affecting chronic hypertension, cardiovascular and respiratory patients, with the aim of raising the standard of remote patient monitoring services and contributing to a future where the impact of various diseases is minimized.

Atalys, a portfolio company of Dunes Point Capital (DPC), acquires Schnipke Engraving, a medical contract manufacturer with injection molding, tooling, and assembly capabilities and 150 employees at two manufacturing facilities in Ohio and Arizona.

Hackensack Meridian Hackensack University Medical Center is one of only 14 centers in the world and the only one in New Jersey, New York and Connecticut to receive Intuitive’s da Vinci 5 multiport surgical system, which was cleared by the US FDA last month, and performed the first procedures on the new system to treat the four patients last week. 

Q Bio launches Tensor Field Mapping, a new technology for Magnetic Resonance Imaging (MRI) that provides detailed insights into the human body that were previously unimaginable, delivering quantitative, harmonised imaging data that can be instantly accessed by AI to accelerate diagnosis.

The US FDA grants De Novo Classification to MMI’s Symani® Surgical System for soft tissue manipulation to perform microsurgery, making it the only commercially available platform for reconstructive microsurgery in the US. The Symani Surgical System offers surgeons new capabilities with the world’s smallest seven-degree-of-freedom robotic surgical wrist, NanoWrist®, which allows surgeons to replicate the natural movements of the human hand at the micro level.

Nectero Medical closes $96 million Series D financing led by Norwest Venture Partners to support US FDA clearance of the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System, an investigational, single-use, endovascular system that delivers pentagalloyl glucose (PGG) locally into the aneurysmal wall, where it binds to elastin and collagen to strengthen the aortic vessel wall and to potentially reduce further degradation.

Genesis MedTech closes a new round of financing of hundreds of millions of RMB (tens of millions of US dollars) led by Wuxi Capital Group and Wuxi Binhu Industrial Investment Development Group, for product development at its Wuxi base and subsequent domestic and international commercialization covering surgical, neurovascular, peripheral vascular, and cardiovascular products.

Nanjing, China-based Tuge Medical raises nearly RMB 200 million ($28 million) in Series B financing, co-led by LongRiver Investments and Shanghai Orient Securities Innovative Investment, to commercialize medical endoscopes, research and develop new products, and strengthen domestic and international sales channels.

en_GBEnglish (UK)